Nanox and Meir Medical Center Start 3D Tomosynthesis Study for Orthopedic Trauma
Nanox launched a clinical trial at Meir Medical Center to evaluate its Nanox.ARC 3D tomosynthesis system for emergency orthopedic injury imaging, comparing it to conventional radiography and CT. The study aims to demonstrate improved anatomical detail, faster diagnostic workflows and reduced radiation dose in high-impact trauma cases.
1. Clinical Collaboration
Nanox Imaging has partnered with Meir Medical Center, part of Clalit Health Services, to conduct a structured clinical study of the Nanox.ARC system in emergency department settings. The trial will compare Nanox.ARC’s multisource digital tomosynthesis against conventional radiography and CT for orthopedic injuries, with an IRB-approved protocol.
2. Nanox.ARC Technology
The Nanox.ARC is a multisource digital tomosynthesis device designed to deliver 3D imaging for musculoskeletal, pulmonary and intra-abdominal applications at reduced cost and radiation dose. Its multi-source architecture aims to provide enhanced visualization of complex anatomical structures that are challenging for 2D X-ray imaging.
3. Study Goals and Impact
The study seeks to demonstrate accelerated diagnostic workflows, higher anatomical detail and reduced radiation exposure in high-impact trauma cases, potentially lowering triage times and improving fracture detection. Positive results could bolster Nanox’s clinical evidence base and support broader adoption across emergency and orthopedic care settings.